Short answer

Cervical cancer screening is prevention perfected: scheduled Pap and HPV testing detects precancerous changes years before invasion, minor procedures remove them, and population programs made a once-common killer rare. For participants.

Screening starts at 21, runs to 65 with adequate negatives, uses Pap and HPV tests in age-staged combinations, and routes abnormal results mostly to surveillance or minor treatment rather than cancer care.

Advertisement

Sponsored: confidential STD testing with results in 1–2 days

Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.

See Tests & Prices →

Schedule by age. The current rhythm (confirm currency yearly)

  • Ages 21–29: Pap (cytology) every 3 years: HPV testing not used alone here (transient infections so common they would over-trigger).
  • Ages 30–65: three accepted options. Co-testing (Pap plus HPV) every 5 years, HPV-primary testing every 5, or Pap alone every 3; confirm which your practice uses and current guideline intervals, since these evolve.
  • Over 65: exit screening with adequate prior negatives and no high-risk history.
  • Immune suppression (including HIV): intensified schedules regardless of age.

The Pap-versus-HPV distinction in detail lives at HPV Testing and Cervical Screening Differences.

How screening works. The visit itself

  • Speculum sampling of cervical cells and HPV DNA (brief pressure lasting minutes. Uncomfortable, rarely painful).
  • Laboratory cytology (cell appearance grading) plus high-risk HPV detection (DNA testing for cancer-associated types).
  • Risk-stratified result routing per guidelines (results map to surveillance, colposcopy, or treatment by algorithm. Not by clinician improvisation).

Knowing the pipeline demystifies the weeks between sampling and results.

Result pathways. What each outcome triggers

  • Both negative: routine interval resumes.
  • HPV-positive with normal Pap: surveillance intervals or genotype-triaged colposcopy (HPV 16/18 genotypes escalate faster).
  • Abnormal Pap grades (ASC-US through HSIL): colposcopy with directed biopsy.
  • Precancer confirmed (CIN2/3): excisional treatment (LEEP most commonly) or ablative treatment, with fertility counseling (most procedures preserve fertility; discuss depth and margins where childbearing is planned).

Abnormal never means cancer at first finding in the overwhelming majority. It means the system working, catching changes years early.

After treatment and special cases. Surveillance continues

  • Post-procedure surveillance schedules (tighter intervals for several years. Keep every one).
  • Pregnancy with abnormal results (deferred management per trimester protocols. Evaluation without endangering pregnancy).
  • Vaccination alongside, not instead of, screening (vaccinated people follow identical schedules: Gardasil covers nine types, not all oncogenic ones, and pre-vaccination exposures persist).

When to seek care

On schedule for routine screens, promptly for result follow-ups (delays defeat screening), and for abnormal bleeding between screens.